Discontinued — last reported Q4 '25
Intercontinental Exchange Interest Paid decreased by 4.7% to $181.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 14.2%, from $211.00M to $181.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 17.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $83.00M | $118.00M | $77.00M | $117.00M | $109.00M | $142.00M | $182.00M | $167.00M | $174.00M | $183.00M | $203.00M | $222.00M | $228.00M | $209.00M | $211.00M | $194.00M | $199.00M | $190.00M | $181.00M |
| QoQ Change | — | +42.2% | -34.7% | +51.9% | -6.8% | +30.3% | +28.2% | -8.2% | +4.2% | +5.2% | +10.9% | +9.4% | +2.7% | -8.3% | +1.0% | -8.1% | +2.6% | -4.5% | -4.7% |
| YoY Change | — | — | — | — | +31.3% | +20.3% | +136.4% | +42.7% | +59.6% | +28.9% | +11.5% | +32.9% | +31.0% | +14.2% | +3.9% | -12.6% | -12.7% | -9.1% | -14.2% |